Home / Facilities / 3007835716

NIPRO VASCULAR CORPORATION FDA Inspection Record

FEI 3007835716 · Inspections, Form 483s, warning letters and import refusals

NIPRO VASCULAR CORPORATION is an FDA-registered facility (FEI 3007835716) located in Nagoya Aichi, JP. RegDataLab tracks 2 FDA inspections at this facility.

Reviewing NIPRO VASCULAR CORPORATION as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check NIPRO VASCULAR CORPORATION yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Apr 3, 2025: No Action Indicated (NAI)
Inspections on record
2 (1 VAI, 1 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Import refusals
10 or more

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Apr 3, 2025No Action Indicated (NAI)No citations listed
Jan 25, 2024Voluntary Action Indicated (VAI)No citations listed

Facility details

Company
Goodman Co., Ltd
Location
Nagoya Aichi (JP)
Source
device

Import refusals

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.